Sex-different association of DAO with schizophrenia in Koreans

Psychiatry Research

Volumn 179, Issue 2, 2010, Pages 121-125

  Kim, Byungsu ^a   Kim, Hyunsook ^a   Joo, Yeon Ho ^a   Lim, Jiyoung ^a   Kim, Chang Yoon ^a   Song, Kyuyoung ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Association study; D amino acid oxidase; Korean; Schizophrenia

Indexed keywords

DEXTRO AMINO ACID OXIDASE;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC LINKAGE; GENOTYPE; HAPLOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; YOUNG ADULT;

ADULT; D-AMINO-ACID OXIDASE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; KOREA; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA; SEX FACTORS; YOUNG ADULT;

EID: 77956186017     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2008.08.009     Document Type: Article

References (28)

1. Addington A.M., Gornick M., Sporn A.L., Gogtay N., Greenstein D., Lenane M., Gochman P., Baker N., Balkissoon R., Vakkalanka R.K., Weinberger D.R., Straub R.E., Rapoport J.L. Polymorphisms in the 13q33.2 gene G72/G30 are associated with childhood-onset schizophrenia and psychosis not otherwise specified. Biological Psychiatry 2004, 55:976-980.
2. Chumakov I., Blumenfeld M., Guerassimenko O., Cavarec L., Palicio M., Abderrahim H., Bougueleret L., Barry C., Tanaka H., La Rosa P., Puech A., Tahri N., Cohen-Akenine A., Delabrosse S., Lissarrague S., Picard F.P., Maurice K., Essioux L., Millasseau P., Grel P., Debailleul V., Simon A.M., Caterina D., Dufaure I., Malekzadeh K., Belova M., Luan J.J., Bouillot M., Sambucy J.L., Primas G., Saumier M., Boubkiri N., Martin-Saumier S., Nasroune M., Peixoto H., Delaye A., Pinchot V., Bastucci M., Guillou S., Chevillon M., Sainz-Fuertes R., Meguenni S., Aurich-Costa J., Cherif D., Gimalac A., Van Duijn C., Gauvreau D., Ouellette G., Fortier I., Raelson J., Sherbatich T., Riazanskaia N., Rogaev E., Raeymaekers P., Aerssens J., Konings F., Luyten W., Macciardi F., Sham P.C., Straub R.E., Weinberger D.R., Cohen N., Cohen D. Genetic and physiological data implicating the new human gene G72 and the gene for d-amino acid oxidase in schizophrenia. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:13675-13680.
3. Chung S., Jung J., Chung H.Y., Yoo H.K., Kim C.Y., Joo Y.H., Choi S.E., Hong J.P. No association between polymorphisms of DAO and DAOA genes and homicidal behaviors in Korean schizophrenia. Psychiatric Genetics 2007, 17:313.
4. Corvin A., Donohoe G., McGhee K., Murphy K., Kenny N., Schwaiger S., Nangle J.M., Morris D., Gill M. d-amino acid oxidase (DAO) genotype and mood symptomatology in schizophrenia. Neuroscience Letters 2007, 426:97-100.
5. Detera-Wadleigh S.D., McMahon F.J. G72/G30 in schizophrenia and bipolar disorder: review and meta-analysis. Biological Psychiatry 2006, 60:106-114.
6. Fallin M.D., Lasseter V.K., Avramopoulos D., Nicodemus K.K., Wolyniec P.S., McGrath J.A., Steel G., Nestadt G., Liang K.Y., Huganir R.L., Valle D., Pulver A.E. Bipolar I disorder and schizophrenia: a 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios. American Journal of Human Genetics 2005, 77:918-936.
7. Fogel W.A. Diamine oxidase (DAO) and female sex hormones. Agents and Actions 1986, 18:44-45.
8. Goldberg T.E., Straub R.E., Callicott J.H., Hariri A., Mattay V.S., Bigelow L., Coppola R., Egan M.F., Weinberger D.R. The G72/G30 gene complex and cognitive abnormalities in schizophrenia. Neuropsychopharmacology 2006, 31:2022-2032.
9. Hong C.J., Hou S.J., Yen F.C., Liou Y.J., Tsai S.J. Family-based association study between G72/G30 genetic polymorphism and schizophrenia. Neuroreport 2006, 17:1067-1069.
10. Javitt D.C., Zukin S.R. Recent advances in the phencyclidine model of schizophrenia. American Journal of Psychiatry 1991, 148:1301-1308.
11. Jotova I., Pavlov V., Dimitrov O., Bachrach U. Developmental aspects of polyamine-oxidizing enzyme activities in the mouse kidney. Effects of testosterone. Amino Acids 1999, 17:267-276.
12. Jotova I., Wang C., Tabib A., Dimitrov O., Bachrach U. Effects of testosterone and 17, beta-estradiol on the polyamine metabolism in cultivated normal rat kidney epithelial cells. Amino Acids 2000, 18:353-361.
13. Kapoor R., Lim K.S., Cheng A., Garrick T., Kapoor V. Preliminary evidence for a link between schizophrenia and NMDA-glycine site receptor ligand metabolic enzymes, d-amino acid oxidase (DAAO) and kynurenine aminotransferase-1 (KAT-1). Brain Research 2006, 1106:205-210.
14. Ko Y.H., Joe S.H., Cho W., Park J.H., Lee J.J., Jung I.K., Kim L., Kim S.H. Estrogen, cognitive function and negative symptoms in female schizophrenia. Neuropsychobiology 2006, 53:169-175.
15. Konno R., Yasumura Y. Mouse mutant deficient in d-amino acid oxidase activity. Genetics 1983, 103:277-285.
16. Lee S.G., Joo Y., Kim B., Chung S., Kim H.L., Lee I., Choi B., Kim C., Song K. Association of Ala72Ser polymorphism with COMT enzyme activity and the risk of schizophrenia in Koreans. Human Genetics 2005, 116:319-328.
17. Liu X., He G., Wang X., Chen Q., Qian X., Lin W., Li D., Gu N., Feng G., He L. Association of DAAO with schizophrenia in the Chinese population. Neuroscience Letters 2004, 369:228-233.
18. Liu Y.L., Fann C.S., Liu C.M., Chang C.C., Wu J.Y., Hung S.I., Liu S.K., Hsieh M.H., Hwang T.J., Chan H.Y., Chen J.J., Faraone S.V., Tsuang M.T., Chen W.J., Hwu H.G. No association of G72 and d-amino acid oxidase genes with schizophrenia. Schizophrenia Research 2006, 87:15-20.
19. Miller R.F. d-serine as a glial modulator of nerve cells. Glia 2004, 47:275-283.
20. Mothet J.P., Parent A.T., Wolosker H., Brady R.O., Linden D.J., Ferris C.D., Rogawski M.A., Snyder S.H. d-serine is an endogenous ligand for the glycine site of the N-methyl-d-aspartate receptor. Proceedings of the National Academy of Sciences of the United States of America 2000, 97:4926-4931.
21. Rao M.L., Kolsch H. Effects of estrogen on brain development and neuroprotection-implications for negative symptoms in schizophrenia. Psychoneuroendocrinology 2003, 28:83-96.
22. Salem J.E., Kring A.M. The role of gender differences in the reduction of etiologic heterogeneity in schizophrenia. Clinical Psychology Review 1998, 18:795-819.
23. Schell M.J. The N-methyl d-aspartate receptor glycine site and d-serine metabolism: an evolutionary perspective. Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences 2004, 359:943-964.
24. Schumacher J., Jamra R.A., Freudenberg J., Becker T., Ohlraun S., Otte A.C., Tullius M., Kovalenko S., Bogaert A.V., Maier W., Rietschel M., Propping P., Nothen M.M., Cichon S. Examination of G72 and d-amino-acid oxidase as genetic risk factors for schizophrenia and bipolar affective disorder. Molecular Psychiatry 2004, 9:203-207.
25. Wake K., Yamazaki H., Hanzawa S., Konno R., Sakio H., Niwa A., Hori Y. Exaggerated responses to chronic nociceptive stimuli and enhancement of N-methyl-d-aspartate receptor-mediated synaptic transmission in mutant mice lacking d-amino-acid oxidase. Neuroscience Letters 2001, 297:25-28.
26. Wood L.S., Pickering E.H., Dechairo B.M. Significant support for DAO as a schizophrenia susceptibility locus: examination of five genes putatively associated with schizophrenia. Biological Psychiatry 2006.
27. Yamada K., Ohnishi T., Hashimoto K., Ohba H., Iwayama-Shigeno Y., Toyoshima M., Okuno A., Takao H., Toyota T., Minabe Y., Nakamura K., Shimizu E., Itokawa M., Mori N., Iyo M., Yoshikawa T. Identification of multiple serine racemase (SRR) mRNA isoforms and genetic analyses of SRR and DAO in schizophrenia and d-serine levels. Biological Psychiatry 2005, 57:1493-1503.
28. Yue W., Kang G., Zhang Y., Qu M., Tang F., Han Y., Ruan Y., Lu T., Zhang J., Zhang D. Association of DAOA polymorphisms with schizophrenia and clinical symptoms or therapeutic effects. Neuroscience Letters 2007, 416:96-100.